Cytokinetics reported $-142310000 in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Acadia Pharmaceuticals ACAD:US USD -27183000 6.83M
Amgen AMGN:US USD 1.62B 527M
Arca Biopharma ABIO:US USD -5676000 1.58M
Bayer BAYN:GR EUR 546M 844M
Biogen BIIB:US USD 1.13B 76.7M
Brainstorm Cell Therapeutics BCLI:US USD -6858000 183K
Bristol Myers Squibb BMY:US USD 2.02B 416M
Cytokinetics CYTK:US USD -142310000 122.49M
Eisai 4523:JP JPY 3.57B 23.33B
Eli Lilly And LLY:US USD 1.94B 486M
Exelixis EXEL:US USD 73.21M 2.54M
Halozyme Therapeutics HALO:US USD 61.63M 38.95M
Intra Cellular Therapies ITCI:US USD -53508000 33.1M
Merk MRK:US USD 3.02B 231M
Novartis NOVN:VX USD 1.57B 121M
Pfizer PFE:US USD 5B 3.61B
Regeneron Pharmaceuticals REGN:US USD 1.2B 118.6M
Roche Holding ROG:VX 8.53B 2.4B